Product Images Cytarabine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Cytarabine NDC 63323-120 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

cyt06 0001 01

cyt06 0001 01

cyt06 0001 02

cyt06 0001 02

cyt06 0001 03

cyt06 0001 03

This is a description of a drug called "SAETELILT Injection" with NDC 63323-120-20. It's a cytotoxic medication administered intravenously, intrathecally, and subcutaneously. It's available in a single-dose vial of 20 ml, containing 2 grams (100 mg per mL) of the medication. The drug is sterile, preservative-free, and requires storage at a controlled room temperature of 20° to 25°C (68° to 77°F) while protecting from light. The medication's usual dosage should be seen in the package insert, and any unused portion should be discarded. The last portion of the text is not readable.*

cyt06 0001 04

cyt06 0001 04

This is a description of a medication called Cytarabine in injection form, used for intravenous, intrathecal, and subcutaneous use. It is available in a 20mL single-dose vial containing 2 grams per 20 mL (100 mg per mL) and is a cytotoxic agent. The usual dosage is indicated on the package insert. The container has NDC 63323-120-20 and is manufactured by Fresenius KaBI in Lake Zurich, IL. The medication should be stored at 20° to 25°C (68° to 77°F), protected from light, and discarded after use. The container closure is not made with natural rubber latex.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.